Adagene Inc. Sponsored ADR (ADAG) vs Bicycle Therapeutics PLC Sponsored ADR (BCYC)

Adagene Inc. Sponsored ADR and Bicycle Therapeutics PLC Sponsored ADR are both Biotechnology companies. Adagene Inc. Sponsored ADR and Bicycle Therapeutics PLC Sponsored ADR are of similar size ($200.1M and $199.4M). Across the 11 metrics below, Adagene Inc. Sponsored ADR leads on 8 and Bicycle Therapeutics PLC Sponsored ADR on 3.

Valuation

Metric ADAG BCYC Biotechnology median
P/E n/m n/m 7.88
P/S n/m 4.21 11.47
P/B n/m 0.50 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 1.13 0.74
EV/Sales n/m (3.78) 10.73
Earnings yield (17.68%) (73.98%) (28.84%)
Free cash flow yield 0.00% (80.86%) (23.03%)

Profitability

Metric ADAG BCYC Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin — (343.60%) 0.00%
Net margin — (311.11%) 0.00%
Free cash flow margin 0.00% (340.29%) 0.00%
Return on equity 0.00% (32.30%) (57.72%)
Return on assets 0.00% (26.47%) (49.22%)
Return on invested capital 0.00% (64,747.54%) 0.00%

Growth

Metric ADAG BCYC Biotechnology median
Revenue growth (TTM) — 217.44% 5.64%
EPS growth (last fiscal year) 49.15% (8.97%) —
Revenue growth, 5-year CAGR 61.38% 47.52% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADAG BCYC Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 5.02 12.08 4.73
Net debt to EBITDA 3.46 2.61 0.96

Dividend

Metric ADAG BCYC Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ADAG BCYC Biotechnology median
Market cap 200.08m 199.41m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack